Related Experiment Video
Updated: Jun 16, 2026
10:27
Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
Published on: November 10, 2015
High-throughput genotyping of mannose-binding lectin variants using high-resolution DNA-melting analysis
Rolf H A M Vossen1, Martine van Duijn, Mohamed R Daha
1Leiden Genome Technology Center, Human and Clinical Genetics, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.
Human Mutation
|February 4, 2010
Summary
High Resolution Melting Analysis (HRMA) enables rapid genotyping of mannose-binding lectin (MBL) gene variants. This novel assay efficiently detects multiple single nucleotide polymorphisms (SNPs) in MBL2, aiding research into immune and inflammatory diseases.
Area of Science:
- Genetics
- Immunology
- Molecular Biology
Background:
- Mannose-binding lectin (MBL) is crucial for innate immunity.
- Single nucleotide polymorphisms (SNPs) in MBL2 influence MBL function and clinical outcomes.
- Accurate and efficient MBL2 genotyping is essential for clinical and research applications.
Purpose of the Study:
- To develop a novel High Resolution Melting Analysis (HRMA) assay for simultaneous detection of three proximal SNPs in the MBL2 first exon.
- To establish a second HRMA assay for a relevant MBL2 promoter polymorphism (Y/X SNP).
- To demonstrate HRMA's suitability for high-throughput MBL2 variant genotyping.
Main Methods:
- Development and application of a novel High Resolution Melting Analysis (HRMA) assay.
- Simultaneous determination of three MBL2 exon 1 SNPs using HRMA with a single non-fluorescent melting probe.
- Analysis of amplicon and probe melting characteristics to discriminate genotypes.
- HRMA assay for detecting the MBL2 promoter Y/X SNP.
Main Results:
- The developed HRMA assay successfully and simultaneously determined three SNPs in the MBL2 first exon.
- Ten distinct MBL2 exon 1 genotypes were discriminated using combined amplicon and probe melting analyses.
- A validated HRMA assay for the MBL2 promoter Y/X SNP was established.
- The assays require no post-PCR processing and are suitable for closed-tube, high-throughput analysis.
Conclusions:
- HRMA is a rapid, sensitive, and efficient method for MBL2 genotyping.
- The developed HRMA assays facilitate high-throughput analysis of MBL2 variants.
- This approach supports further clinical studies on MBL's role in inflammatory and infectious diseases.
